HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
Shim, J.H., Kim, H.S., Cha, H., Kim, S., Kim, T.M., Anagnostou, V., Choi, Y.-L., Jung, H.A., Sun, J.-M., Ahn, J.S., Ahn, M.-J., Park, K., Park, W.-Y., Lee, S.-H.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
Lee, S.-H., Lee, J.-K., Ahn, M.-J., Kim, D.-W., Sun, J.-M., Keam, B., Kim, T.M., Heo, D.S., Ahn, J.S., Choi, Y.-L., Min, H.-S., Jeon, Y.K., Park, K.
Published in Annals of oncology (01.02.2017)
Published in Annals of oncology (01.02.2017)
Get full text
Journal Article
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
Lim, S.H, Hong, M, Ahn, S, Choi, Y.-L, Kim, K.-M, Oh, D, Ahn, Y.C, Jung, S.-H, Ahn, M.-J, Park, K, Zo, J.I, Shim, Y.M, Sun, J.-M
Published in European journal of cancer (1990) (01.01.2016)
Published in European journal of cancer (1990) (01.01.2016)
Get full text
Journal Article
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
Park, S., Lee, M.-H., Seong, M., Kim, S.T., Kang, J.-H., Cho, B.C., Lee, K.H., Cho, E.K., Sun, J.-M., Lee, S.-H., Ahn, J.S., Park, K., Ahn, M.-J.
Published in Annals of oncology (01.10.2020)
Published in Annals of oncology (01.10.2020)
Get full text
Journal Article
Posttraumatic administration of a sub-anesthetic dose of ketamine exerts neuroprotection via attenuating inflammation and autophagy
Wang, C.-Q., Ye, Y., Chen, F., Han, W.-C., Sun, J.-M., Lu, X., Guo, R., Cao, K., Zheng, M.-J., Liao, L.-C.
Published in Neuroscience (20.02.2017)
Published in Neuroscience (20.02.2017)
Get full text
Journal Article
Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing
Sun, J.-M., Choi, Y.-L., Ji, J.H., Ahn, J.S., Kim, K.-M., Han, J., Ahn, M.-J., Park, K.
Published in Annals of oncology (01.01.2015)
Published in Annals of oncology (01.01.2015)
Get full text
Journal Article
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
Sun, J.-M., Ahn, Y.C., Choi, E.K., Ahn, M.-J., Ahn, J.S., Lee, S.-H., Lee, D.H., Pyo, H., Song, S.Y., Jung, S.-H., Jo, J.S., Jo, J., Sohn, H.J., Suh, C., Lee, J.S., Kim, S.-W., Park, K.
Published in Annals of oncology (01.08.2013)
Published in Annals of oncology (01.08.2013)
Get full text
Journal Article
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer
Lim, S.H., Lee, J.Y., Lee, M.-Y., Kim, H.S., Lee, J., Sun, J.-M., Ahn, J.S., Um, S.-W., Kim, H., Kim, B.S., Kim, S.T., Na, D.L., Sun, J.Y., Jung, S.H., Park, K., Kwon, O.J., Lee, J.-I., Ahn, M.-J.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
Park, S., Sun, J.-M., Choi, Y.-L., Oh, D., Kim, H.K., Lee, T., Chi, S.A., Lee, S.-H., Choi, Y.S., Jung, S.-H., Ahn, M.-J., Ahn, Y.C., Park, K., Shim, Y.M.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
NSCLC with well controlled extra-cranial disease but uncontrolled brain metastases
Jung, H.A., Park, K., Sun, J.-M., Lee, S.H., Ahn, J.S., Ahn, M.-J., Park, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer
Kato, K., Shah, M.A., Enzinger, P.C., Bennouna, J., Shen, L., Adenis, A., Sun, J.-M., Cho, B.C., Ozguroglu, M., Kojima, T., Kostorov, V., Hierro, C., Zhu, Y., Shah, S., Bhagia, P., Doi, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article